Insta
Bharat Biotech’s COVAXIN, India’s first indigenous vaccine against coronavirus. (Swarajya Magazine)
Bharat Biotech announced on Thursday that it's Covid-19 vaccine, Covaxin, has received a certificate of Good Manufacturing Practice (GMP) compliance from the Hungarian authorities.
The approval has been received from the National Institute of Pharmacy and Nutrition, Hungary, certifying the GMP for the manufacture of Covaxin.
The certificate of GMP is now listed on the EudraGMDP database, which is the database of the European Community of manufacturing authorizations and certificates of the good manufacturing practice, the Hyderabad-based vaccine maker said.
Bharat Biotech intends to submit documentation for Emergency Use Authorization (EUA) in several additional countries worldwide.
With this approval, Bharat Biotech has achieved another significant milestone in innovating and manufacturing vaccines at global quality standards and moving forward in the ongoing fight against the Covid-19 pandemic.
The recognition complements our commitment of driving world-class innovation and being a frontrunner in the research and development of vaccines, it said.
This news has been published via a Syndicated feed. Only the headline is changed.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.
Latest